What is Low Dose Naltrexone?

Naltrexone is an FDA approved medication that is structurally and functionally similar to naloxone. Normal doses of Naltrexone (50-100 mg) are indicated for the treatment of opioid addiction for patients addicted to heroin or opium products.

However, low dose Naltrexone (LDN) refers to daily dosages of Naltrexone that are less than the typical opioid addiction treatment dosage, commonly up to 5 mg. At the low dose level, Naltrexone exhibits paradoxical properties, including analgesia and anti-inflammatory actions. Low dose Naltrexone has been found to be beneficial in a variety of conditions and diseases, which include:

  • ALS
  • Alzheimer’s Disease
  • Autoimmune Hepatitis
  • Celiac Disease
  • Crohn’s Disease
  • Inflammatory Bowel Disease
  • Multiple Sclerosis
  • CFS/ME
  • Complex Regional Pain Syndrome
  • Lyme Disease
  • Hashimoto’s Thyroiditis
  • Grave’s Disease
  • Diabetes Type I
  • Vitiligo
  • Scleroderma
  • Psoriasis
  • Anxiety and Depression
  • Fertility
  • PCOS
  • Melanoma
  • Nerve Pain
  • Glioblastoma
  • Esophageal and Oral Cancer
  • Non-Small Cell Cancer
  • Breast Cancer
  • Multiple Myeloma
  • Lymphoma
  • Ovarian Cancer
  • Renal Cell Cancer
  • Colorectal Cancer
  • Duodenal and Stomach Cancer
  • Uterine Cancer
  • Hepatic Cancer